MU Investments Company’s AbbVie ABBV Stock Holding History

MU Investments Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-220	Closed	-$22K	–	26
2017 Q4	$22K	Sell	220 -100	-31%	-$9.43K	0.02%	129
2017 Q3	$28K	Sell	320 -100	-24%	-$7.61K	0.02%	129
2017 Q2	$30K	Sell	420 -130	-24%	-$8.74K	0.02%	153
2017 Q1	$36K	Sell	550 -160	-23%	-$10.1K	0.03%	156
2016 Q4	$45K	Sell	710 -290	-29%	-$17.7K	0.03%	155
2016 Q3	$63K	Sell	1,000 -1,050	-51%	-$68K	0.05%	149
2016 Q2	$127K	Sell	2,050 -1,100	-35%	-$67K	0.09%	135
2016 Q1	$180K	Hold	3,150	–	–	0.11%	145
2015 Q4	$185K	Sell	3,150 -2,480	-44%	-$143K	0.11%	156
2015 Q3	$297K	Sell	5,630 -300	-5%	-$19.5K	0.16%	114
2015 Q2	$398K	Sell	5,930 -1,400	-19%	-$91.4K	0.19%	91
2015 Q1	$427K	Sell	7,330 -300	-4%	-$18.1K	0.2%	90
2014 Q4	$511K	Buy	7,630 +300	+4%	+$18.9K	0.22%	80
2014 Q3	$429K	Sell	7,330 -1,090	-13%	-$60.5K	0.21%	84
2014 Q2	$478K	Sell	8,420 -800	-9%	-$42K	0.22%	85
2014 Q1	$470K	Sell	9,220 -1,200	-12%	-$60.6K	0.22%	87
2013 Q4	$552K	Buy	10,420 +290	+3%	+$14.3K	0.24%	88
2013 Q3	$449K	Sell	10,130 -4,100	-29%	-$182K	0.21%	109
2013 Q2	$614K	Buy	+14,230	New	+$622K	0.26%	108

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MU Investments Company's ABBV Position: Q1 2018 in Review

MU Investments Company sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 220 shares — an estimated $22K sold.

MU Investments Company first reported a position in ABBV in Q2 2013 and held it in 19 quarters. The position peaked at $614K in Q2 2013. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

MU Investments Company reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
MU Investments Company sold 220 AbbVie shares in Q1 2018, an estimated $22K.
MU Investments Company first reported a position in AbbVie in Q2 2013 and held it in 19 quarters.
MU Investments Company's AbbVie position peaked at $614K in Q2 2013.
2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on MU Investments Company's 13F filing for Q1 2018, filed 20 Apr 2018.